<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
	<title>BioToday.com [新着ニュース]</title>
	<description>BioToday.comは医学情報、バイオテクノロジー、バイオベンチャー関連ニュースのデータベースです。</description>
	<link>http://www.biotoday.com/news.cfm</link>
	<managingEditor>biotoday@biotoday.com</managingEditor>
	<copyright>Copyright &#169; 2026 BioToday Ltd. All Rights Reserved.</copyright>
	<lastBuildDate>Fri, 10 Apr 2026 17:03:18 +0900</lastBuildDate>
	<language>ja</language>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<item>
		<title>[医学] GLP1受容体活性化薬の体重減少の個人差と関連する遺伝配列変化を同定</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109624&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109624&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 10 Apr 2026 17:03:18 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109624&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Sox9のエンハンサーEnh13配列の僅かな変化で雌マウスに精巣が生じる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109623&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109623&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 10 Apr 2026 13:49:28 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109623&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 秘密の化合物compound Xがパーキンソン病関連タンパク質αシヌクレインを除去</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109622&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109622&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 10 Apr 2026 12:20:48 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109622&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 1人の女性の3つの自己免疫疾患が元凶のB細胞を駆除する自己T細胞投与で解消</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109621&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109621&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 10 Apr 2026 11:20:08 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109621&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 脳の掃除を促して片頭痛を和らげる効果が降圧薬プラゾシンにあるかもしれない</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109620&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109620&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 09 Apr 2026 16:54:15 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109620&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] インフルエンザワクチンは将来のインフルエンザへの免疫反応の備えも生み出す</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109619&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109619&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 09 Apr 2026 16:07:33 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109619&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] SRSF2変異骨髄異形成症候群にIL-1β阻害が有益らしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109618&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109618&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 09 Apr 2026 15:21:58 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109618&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] αシヌクレイン凝集阻害フォルダマーSK-129がマウスのシヌクレイン病を治療</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109617&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109617&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 09 Apr 2026 13:57:34 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109617&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] BAP1変異癌にBAP1阻害薬SP2509とLSD1阻害薬olaparibの併用が有効らしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109616&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109616&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 09 Apr 2026 11:23:48 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109616&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 皮膚に刺した極細針で薬の行く方や代謝機能を測定するウェアラブル装置を開発</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109615&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109615&amp;ref=rss</guid>
		<category>技術 / 診断 / 全般</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 09 Apr 2026 10:59:57 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109615&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] アステラス製薬が骨格筋への運び手のAAVカプシドを手に入れる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109614&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109614&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 09 Apr 2026 09:58:51 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109614&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 超音波による治療を開発するSonoNeu社が最大4130万ドルの助成を積んで船出</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109613&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109613&amp;ref=rss</guid>
		<category>ビジネス / 会社運営 / 開業</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 09 Apr 2026 08:51:11 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109613&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 病期3大腸癌の切除後のTecentriq込み治療で無病生存が改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109612&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109612&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 08 Apr 2026 16:44:52 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109612&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 無症状の大動脈弁狭窄をすぐに大動脈弁置換手術（SAVR）する取り柄が10年継続</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109611&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109611&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 08 Apr 2026 16:23:05 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109611&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 心筋梗塞から1年経つβ遮断薬使用は止めてよさそう</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109610&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109610&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 08 Apr 2026 16:00:33 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109610&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Editas社が手を引いた遺伝子編集治療reni-celのβサラセミア相手のPh1/2試験論文</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109609&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109609&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 08 Apr 2026 15:29:31 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109609&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Praxis社の発達性てんかん性脳症（DEE）薬elsunersenがPh1/2試験で有効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109608&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109608&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 08 Apr 2026 15:03:27 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109608&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Gileadが装填抗体（ADC）のTubulis社を買う</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109607&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109607&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 08 Apr 2026 12:46:28 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109607&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Sanofiの抗IL13/TSLP薬が呼吸器疾患Ph2試験2つで振るい、皮膚疾患では倒れる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109606&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109606&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 08 Apr 2026 11:26:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109606&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Insmed社のDPP1阻害薬Brinsupriの化膿性汗腺炎Ph2b試験失敗</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109605&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109605&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 08 Apr 2026 10:48:20 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109605&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 鎌状赤血球症患者の胎児ヘモグロビンがBeam社の塩基編集治療で見込み通り増加</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109604&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109604&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 08 Apr 2026 10:23:39 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109604&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 下肢動脈疾患へのConcept Medical社のシロリムス被覆バルーンMagicTouchが有益</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109603&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109603&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 08 Apr 2026 09:47:41 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109603&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 複雑PCIでの血管内超音波検査の取り柄が1試験で示され、2試験では示せず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109602&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109602&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 07 Apr 2026 16:41:21 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109602&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Neurocrine社がSoleno社を買ってプラダーウィリー症候群薬Vykat XRを手にする</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109601&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109601&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 07 Apr 2026 16:11:57 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109601&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 重度心不全患者の込み入ったPCIでの心機能補助ポンプ併用の取り柄示せず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109600&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109600&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 07 Apr 2026 15:35:05 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109600&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 甲状腺眼症へのAmgenのTepezza皮下注射のPh3試験成功</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109599&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109599&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 07 Apr 2026 14:45:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109599&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 閉塞性肥大型心筋症の18歳未満若者にBMSの心筋ミオシン阻害薬Camzyosが有効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109598&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109598&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 07 Apr 2026 13:41:00 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109598&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 血管造影から算出する血流予備量頼りの冠血行再建が圧ワイヤー頼みに劣らず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109597&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109597&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 07 Apr 2026 10:31:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109597&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Boston Scientificのカテーテル装置での超音波とtPA投与の肺塞栓治療がより有効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109596&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109596&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 06 Apr 2026 15:27:18 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109596&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 人工知能が乳癌薬の抗ウイルス作用を予想し、動物実験でその効果が示された</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109595&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109595&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 06 Apr 2026 13:15:13 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109595&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 臨床試験でデクスメデトミジンがアルツハイマー病関連蛋白質除去を促進</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109594&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109594&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 06 Apr 2026 12:20:52 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109594&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 抗凝固薬が向く心房細動患者の左心耳閉鎖がNOAC抗凝固薬に劣らず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109593&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109593&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 05 Apr 2026 17:00:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109593&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 動脈硬化疾患患者のLDLコレステロールをより下げるのが有益〜韓国無作為化試験</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109592&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109592&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 05 Apr 2026 14:45:43 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109592&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 無作為化試験で経皮エストラジオール前立腺癌治療がLHRHに比肩</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109591&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109591&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 05 Apr 2026 14:08:07 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109591&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 先立つ治療を経ている進行固形癌患者3-4人に1人にG12D変異KRAS分解薬が有効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109590&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109590&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第1相試験 || ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 05 Apr 2026 13:20:54 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109590&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ブタ精液の小胞を利用した点眼薬でマウスの網膜芽細胞腫の増殖を阻止</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109589&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109589&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 05 Apr 2026 12:19:48 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109589&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Denali社との前頭側頭型認知症薬DNL593の提携を武田薬品が打ち切り</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109588&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109588&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 05 Apr 2026 10:20:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109588&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 1年近く前に米国FDAが差し止めたHIV薬Ph2/3試験の1つをGilead社が打ち切り</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109587&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109587&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 中止 || 開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 05 Apr 2026 09:44:03 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109587&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] AstraZenecaの手持ち2品ImfinziとImjudo込み初期肝癌治療の無増悪生存改善達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109586&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109586&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 05 Apr 2026 08:40:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109586&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Immunovant社で二の次扱いのFcRn阻害薬が発奮せず甲状腺眼症Ph3試験失敗</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109585&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109585&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 04 Apr 2026 16:52:09 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109585&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 統合失調症絡みの認知障害へのAlto社のPDE4阻害薬ALTO-101のPh2試験失敗</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109584&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109584&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 04 Apr 2026 16:28:05 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109584&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] PfizerとBioNTechの新装COVID-19ワクチンの米国大規模試験が不人気で停止</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109583&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109583&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / その他臨床試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 04 Apr 2026 15:55:29 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109583&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 脳の線条体の神経で発現するPDE10Aの阻害薬をAxsome社が武田薬品から取得</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109582&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109582&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 04 Apr 2026 15:19:17 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109582&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] ORIC社のPh1b試験段階の前立腺癌薬のPh3試験用量が決まる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109581&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109581&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 04 Apr 2026 14:56:55 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109581&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 血液癌を治療するOrca Bio社の細胞詰め合わせOrca-Tの米国承認審査3か月延長</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109580&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109580&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認申請</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 04 Apr 2026 12:29:48 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109580&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Enveda社のJak阻害様経口薬ENV-294でアトピー性皮膚炎患者のEASIが68%低下</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109579&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109579&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第1相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 04 Apr 2026 11:53:28 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109579&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] EPP/XLP患者の耐日光時間が田辺のdersimelagonでプラセボ差し引き30分延長</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109578&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109578&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 04 Apr 2026 10:58:39 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109578&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Insilico Medicine社との新規提携でLillyが前臨床段階の経口治療の権利を取得</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109577&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109577&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 04 Apr 2026 10:17:34 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109577&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Amgenの補体5a受容体阻害薬Tavneosの深刻な肝障害の注意を米国FDAが発した</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109576&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109576&amp;ref=rss</guid>
		<category>ビジネス / トラブル / 安全性</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 03 Apr 2026 16:57:45 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109576&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] BiogenがApellis社を56億ドルほどで買って承認済みの補体阻害薬を手にする</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109575&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109575&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 03 Apr 2026 16:07:57 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109575&amp;ref=rss</comments>
	</item>
</channel>
</rss>
